Clinical study of minimally invasive Neuro-interventional analgesia in the treatment of cancer pain

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044014

Enrollment

Unknown

Registered

2021-03-06

Start date

2021-03-01

Completion date

Unknown

Last updated

2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer pain

Interventions

Calcium channel blockers and opioid group:Calcium channel blockers and opioid

Minimally invasive nerve intervention analgesia group :Minimally invasive nerve intervention analgesia

opioid group:opioid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Over 18 years old, diagnosed with cancer-related pain, life expectancy more than 3 months.

Exclusion criteria

Exclusion criteria: Severe heart, lung, brain, liver and kidney disease, infection or tumor at puncture site, abnormal blood coagulation, mental disorder, unable to cooperate.

Design outcomes

Primary

Measure	Time frame
NRS;LANSS;	—

Secondary

Measure	Time frame
SF-36 scale;	—

Countries

China

Contacts

Public ContactSima Lei

China-Japan Friendship Hospital

simalei75@126.com+86 10-84205335

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026